MMDA-2

MMDA-2 is a psychedelic drug and a substituted amphetamine. It is a member of the methylenedioxyphenethylamine class and is chemically related to MDMA and MMDA.

History

MMDA-2 was first synthesized by Alexander Shulgin, a renowned American medicinal chemist and psychopharmacologist. Shulgin documented his findings in his book PiHKAL: A Chemical Love Story, where he described the effects of MMDA-2 as being similar to MMDA, but with a longer duration.

Chemistry

MMDA-2 is a phenethylamine derivative with a methylenedioxy group attached to the benzene ring. It is structurally similar to other psychedelic phenethylamines such as mescaline and 2C-B. The compound is chiral, and the S-isomer is the more active form.

Pharmacology

The exact mechanism of action of MMDA-2 is not fully understood. However, it is believed to act as a serotonin receptor agonist, similar to other psychedelic drugs. It may also have activity at other receptor sites in the brain.

Effects

The effects of MMDA-2 are reported to be similar to those of other psychedelic drugs, including altered perception, enhanced visual and auditory sensations, and introspective experiences. The duration of effects is typically longer than that of MMDA, lasting up to 12 hours.

Legal Status

The legal status of MMDA-2 varies by country. In the United States, it is classified as a Schedule I drug under the Controlled Substances Act, meaning it has a high potential for abuse and no accepted medical use.

See Also

• Phenethylamine
• Psychedelic drug
• Alexander Shulgin
• PiHKAL